Table 1 Demographic and disease characteristics (N = 40)
Variable | SPIN-SELF | Usual care |
|---|---|---|
N = 26 | N = 14 | |
Demographic | ||
 Age in years, mean (SD) | 54.7 (11.3) | 62.9 (7.3) |
 Female sex, N (%) | 24 (92.3) | 13 (92.9) |
 Education in years, mean (SD) | 15.6 (3.1) | 15.6 (3.0) |
 Married or living as married, N (%) | 19 (73.1) | 10 (71.4) |
Race/ethnicity, N (%) | ||
 White | 21 (80.8) | 12 (85.7) |
 Black | 2 (7.7) | 2 (14.3) |
 Other | 3 (11.5) | 0 (0.0) |
Country, N (%) | ||
 Canada | 9 (34.6) | 4 (28.6) |
 The USA | 12 (46.2) | 7 (50.0) |
 The UK | 5 (19.2) | 3 (21.4) |
Disease characteristicsa | ||
 Time since onset first non-Raynaud’s symptom or sign in years, mean (SD) | 16.7 (9.3)b | 12.7 (7.3)c |
 Time since diagnosis in years, mean (SD) | 13.0 (8.3)d | 10.6 (5.2) |
 Diffuse disease subtype, N (%) | 11 (44.0)e | 8 (50.0) |
Self-Efficacy for Managing Chronic Disease Scale score (SEMCD) | ||
 SEMCD Scale score, mean (SD) | 5.0 (1.5) | 4.8 (1.2) |
PROMIS-29 | ||
 Physical function score, mean (SD) | 39.2 (8.1)e | 39.6 (9.9) |
 Anxiety score, mean (SD) | 56.8 (8.7)e | 53.1 (9.1) |
 Depression score, mean (SD) | 54.9 (9.5)e | 53.2 (9.0) |
 Fatigue score, mean (SD) | 63.2 (8.1)e | 57.8 (11.8) |
 Sleep disturbance score, mean (SD) | 55.4 (7.2)e | 52.4 (6.7) |
 Social roles and activities score, mean (SD) | 40.7 (5.9)e | 43.8 (11.5) |
 Pain interference score, mean (SD) | 58.5 (7.0)e | 61.8 (7.8) |
 Single item for pain intensity, mean (SD) | 4.8 (2.2)e | 4.9 (2.6) |